Paul Tutac
Overview
Explore the profile of Paul Tutac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prodan-Barbulescu C, Alin C, Faur I, Bujor G, Seclaman E, Enatescu V, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457478
Backround: Depression is a significant concern in clinical and preclinical psychoneurobiological sciences due to its high prevalence and its individual and collective consequences. Identifying efficient biomarkers for accurate diagnosis is...
2.
Prodan-Barbulescu C, Ghenciu L, Seclaman E, Bujor G, Enatescu V, Danila A, et al.
Curr Issues Mol Biol
. 2024 Oct;
46(10):10846-10853.
PMID: 39451524
Major depressive disorder (MDD) is a complex mental health condition with a multifaceted and incompletely elucidated pathophysiology. MicroRNAs (miRNAs) have emerged as potential biomarkers due to their role in gene...
3.
Prodan-Barbulescu C, Seclaman E, Enatescu V, Faur I, Ghenciu L, Tutac P, et al.
Biomedicines
. 2024 Mar;
12(3).
PMID: 38540129
The most prevalent mental illness worldwide and the main contributor to suicide and disability is major depressive disorder. Major depressive disorder is now diagnosed and treated based on the patient's...
4.
Prodan-Barbulescu C, Watz C, Moaca E, Faur A, Dehelean C, Faur F, et al.
Medicina (Kaunas)
. 2024 Feb;
60(2).
PMID: 38399496
: Nowadays, the development of enabled pharmaceutical nanoparticles of solid lipid type is continuously growing, because they have the potential to be used for targeted drug release leading to an...
5.
Chirita-Emandi A, Serban C, Paul C, Andreescu N, Velea I, Mihailescu A, et al.
Diabetes Metab Syndr Obes
. 2020 Nov;
13:4483-4494.
PMID: 33239899
Introduction: Insulin resistance plays a major role in metabolic syndrome and is recognized as the most common risk factor for non-alcoholic fatty liver disease (NAFLD). Identifying predictors for insulin resistance...
6.
Chirita-Emandi A, Andreescu N, Zimbru C, Tutac P, Arghirescu S, Serban M, et al.
Sci Rep
. 2020 Jan;
10(1):223.
PMID: 31937788
The benefit of reporting unsolicited findings in Next Generation Sequencing (NGS) related to cancer genes in children may have implications for family members, nevertheless, could also cause distress. We aimed...
7.
Serafim V, Chirita-Emandi A, Andreescu N, Tiugan D, Tutac P, Paul C, et al.
Nutrients
. 2019 Nov;
11(11).
PMID: 31671528
Polyunsaturated fatty acids (PUFAs) play important roles in health and disease. PUFA levels are influenced by nutrition and genetic factors. The relationship between PUFA composition in red blood cells (RBCs)...
8.
Chirita-Emandi A, Munteanu D, Andreescu N, Tutac P, Paul C, Velea I, et al.
J Pediatr Endocrinol Metab
. 2019 Mar;
32(1):33-39.
PMID: 30864372
Background Previous genome-wide association studies (GWAS) identified IGF1, IRS1, GCKR, PPARG, GCK1 and KCTD1 as candidate genes for insulin resistance and type 2 diabetes (T2D). We investigated the associations of...